["{\n\"step_by_step_thinking\": \"From the provided documents, it is clear that patients with systemic lupus erythematosus (SLE) have an interferon inhibitor in their blood circulation. This inhibitor can block antiviral activity of all three types of human interferons and can significantly reduce the synthesis of interferon alpha by treated lymphocytes obtained from normal healthy individuals. Additionally, it is mentioned that an interferon inhibitory activity was not detected in any of the sera taken from normal healthy individuals. Therefore, it can be inferred that SLE patients have a distinct interferon signature.\",\n\"answer_choice\": \"A\"\n}"]